» Articles » PMID: 23907496

Impact of Chronic Liver Disease in Intensive Care Unit Acquired Pneumonia: a Prospective Study

Overview
Specialty Critical Care
Date 2013 Aug 3
PMID 23907496
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To assess the impact of chronic liver disease (CLD) on ICU-acquired pneumonia.

Methods: This was a prospective, observational study of the characteristics, microbiology, and outcomes of 343 consecutive patients with ICU-acquired pneumonia clustered according to the presence of CLD.

Results: Sixty-seven (20%) patients had CLD (67% had liver cirrhosis, LC), MELD score 26 ± 9, 20% Child-Pugh class C). They presented higher severity scores than patients without CLD both on admission to the ICU (APACHE II, LC 19 ± 6 vs. other CLD 18 ± 6 vs. no CLD 16 ± 6; p < 0.001; SOFA, 10 ± 3 vs. 8 ± 4 vs. 7 ± 3; p < 0.001) and at onset of pneumonia (APACHE II, 19 ± 6 vs. 17 ± 6 vs. 16 ± 5; p = 0.001; SOFA, 11 ± 4 vs. 9 ± 4 vs. 7 ± 3; p < 0.001). Levels of CRP were lower in patients with LC than in the other two groups (day 1, 6.5 [2.5-11.5] vs. 13 [6-23] vs. 15.5 [8-24], p < 0.001, day 3, 6 [3-12] vs. 16 [9-21] vs. 11 [5-20], p = 0.001); all the other biomarkers were higher in LC and other CLD patients. LC patients had higher 28- and 90-day mortality (63 vs. 28%, p < 0.001; 72 vs. 38%, p < 0.001, respectively) than non-CLD patients. Presence of LC was independently associated with decreased 28- and 90-day survival (95% confidence interval [CI], 1.982-17.250; p = 0.001; 95% confidence interval [CI], 2.915-20.699, p = 0.001, respectively).

Conclusions: In critically ill patients with ICU-acquired pneumonia, CLD is associated with a more severe clinical presentation and poor clinical outcomes. Moreover, LC is independently associated with 28- and 90-day mortality. The results of this study are important for future trials focused on mortality.

Citing Articles

Factors Associated with Mortality in Nosocomial Lower Respiratory Tract Infections: An ENIRRI Analysis.

Reyes L, Torres A, Olivella-Gomez J, Ibanez-Prada E, Nseir S, Ranzani O Antibiotics (Basel). 2025; 14(2).

PMID: 40001371 PMC: 11851455. DOI: 10.3390/antibiotics14020127.


Adverse Outcomes of Patients with Non-Ventilator-Associated Hospital-Acquired Pneumonia (nvHAP)-A Single Centre Cohort Study.

Amodio E, Schreiber P, Faes Hesse M, Wolfensberger A Infect Dis Rep. 2024; 16(2):228-238.

PMID: 38525765 PMC: 10961785. DOI: 10.3390/idr16020018.


Are Cirrhotic Patients Receiving Invasive Mechanical Ventilation at Risk of Abundant Microaspiration.

Levy C, Gaudet A, Jaillette E, Reignier J, Lassailly G, Balduyck M J Clin Med. 2022; 11(20).

PMID: 36294314 PMC: 9604551. DOI: 10.3390/jcm11205994.


Liver stiffness is associated with disease severity and worse clinical scenarios in coronavirus disease 2019: A prospective transient elastography study.

Demirtas C, Keklikkiran C, Ergenc I, Erturk Sengel B, Eskidemir G, Cinel I Int J Clin Pract. 2021; 75(9):e14363.

PMID: 33993597 PMC: 8237050. DOI: 10.1111/ijcp.14363.


Chronic liver disease is not associated with severity or mortality in Coronavirus disease 2019 (COVID-19): a pooled analysis.

Lippi G, de Oliveira M, Henry B Eur J Gastroenterol Hepatol. 2020; 33(1):114-115.

PMID: 32282549 PMC: 7690326. DOI: 10.1097/MEG.0000000000001742.


References
1.
Fagon J, Chastre J, HANCE A, Montravers P, Novara A, Gibert C . Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med. 1993; 94(3):281-8. DOI: 10.1016/0002-9343(93)90060-3. View

2.
Garcia-Tsao G . Bacterial infections in cirrhosis. Can J Gastroenterol. 2004; 18(6):405-6. DOI: 10.1155/2004/769615. View

3.
Kollef M . Review of recent clinical trials of hospital-acquired pneumonia and ventilator-associated pneumonia: a perspective from academia. Clin Infect Dis. 2010; 51 Suppl 1:S29-35. DOI: 10.1086/653037. View

4.
Huang D, Angus D, Kellum J, Pugh N, Weissfeld L, Struck J . Midregional proadrenomedullin as a prognostic tool in community-acquired pneumonia. Chest. 2009; 136(3):823-831. PMC: 2818411. DOI: 10.1378/chest.08-1981. View

5.
Fernandez J, Navasa M, Gomez J, Colmenero J, Vila J, Arroyo V . Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology. 2002; 35(1):140-8. DOI: 10.1053/jhep.2002.30082. View